PAP

Persistent Asset Partners Portfolio holdings

AUM $114M
This Quarter Return
+9.54%
1 Year Return
3 Year Return
5 Year Return
10 Year Return
AUM
$114M
AUM Growth
+$822K
Cap. Flow
-$2.62M
Cap. Flow %
-2.3%
Top 10 Hldgs %
34.23%
Holding
207
New
51
Increased
27
Reduced
32
Closed
45

Sector Composition

1 Healthcare 61.17%
2 Financials 18.93%
3 Materials 5.9%
4 Technology 3.43%
5 Energy 2.34%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GOSS icon
151
Gossamer Bio
GOSS
$668M
-61,984
Closed -$68.2K
GPK icon
152
Graphic Packaging
GPK
$6.38B
-8,966
Closed -$233K
IBOC icon
153
International Bancshares
IBOC
$4.45B
-14,953
Closed -$943K
IMUX icon
154
Immunic
IMUX
$75.1M
0
INDB icon
155
Independent Bank
INDB
$3.55B
-5,382
Closed -$337K
IWM icon
156
iShares Russell 2000 ETF
IWM
$67.8B
0
KALV icon
157
KalVista Pharmaceuticals
KALV
$796M
-34,098
Closed -$393K
KRE icon
158
SPDR S&P Regional Banking ETF
KRE
$3.99B
0
KROS icon
159
Keros Therapeutics
KROS
$633M
0
LC icon
160
LendingClub
LC
$1.9B
-119,628
Closed -$1.23M
LDI icon
161
loanDepot
LDI
$605M
-122,159
Closed -$145K
LXRX icon
162
Lexicon Pharmaceuticals
LXRX
$396M
0
MCK icon
163
McKesson
MCK
$85.5B
-2,628
Closed -$1.77M
MLTX icon
164
MoonLake Immunotherapeutics
MLTX
$3.77B
0
MNKD icon
165
MannKind Corp
MNKD
$1.7B
0
MODV
166
DELISTED
ModivCare
MODV
-8,757
Closed -$11.5K
MREO
167
Mereo BioPharma
MREO
$282M
-113,247
Closed -$255K
MRNA icon
168
Moderna
MRNA
$9.78B
0
NKTR icon
169
Nektar Therapeutics
NKTR
$764M
0
NVDA icon
170
NVIDIA
NVDA
$4.07T
0
NVO icon
171
Novo Nordisk
NVO
$245B
-5,859
Closed -$407K
OCUL icon
172
Ocular Therapeutix
OCUL
$2.37B
0
OEF icon
173
iShares S&P 100 ETF
OEF
$22.1B
0
PFE icon
174
Pfizer
PFE
$141B
0
PRTA icon
175
Prothena Corp
PRTA
$460M
0